Hypogonadism Completed Phase 3 Trials for Lutropin alfa (DB00044)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01084265A Study Using Recombinant Human Luteinizing Hormone (r-hLH, LuverisĀ®) in the Treatment of Chinese Women With Hypogonadotropic HypogonadismTreatment